What’s Driving Growth in the Gene Therapy Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the gene therapy market grown in recent years?
In recent times, the growth of the gene therapy market size has been exponential. The market is projected to expand from $12.52 billion in 2024 to $16.36 billion in 2025 with a compound annual growth rate (CAGR) of 30.7%. The historical growth can be traced back to increasing pharmaceutical research and development expenditures, growing public-private collaborations, government funding, and an uptick in spinal muscular atrophy instances.
How is the gene therapy market size expected to evolve during the forecast period?
Anticipated to witness a significant rise in the next couple of years, the market size of geospatial analytics is projected to reach $209.26 billion in 2029 with an impressive compound annual growth rate of 19.0%. The surge during the forecast period can be linked to various factors such as the establishment of smart cities, the implementation of precision farming, healthcare and epidemic tracking, amalgamation with IoT and huge data, as well as environmental preservation initiatives. Key trends during the forecast timeframe include geospatial big data analytics, mobile geospatial applications, blockchain interfaces for spatial data protection, social media combined with geospatial analysis, and urban mobility along with smart city planning.
Get your gene therapy market report here!
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Which key drivers are propelling the gene therapy market’s growth?
Significant growth in the gene therapy market is being driven by the escalating incidents of cancer and various other diseases requiring effective treatment. The global increase in cancer cases is expected to contribute to the expansion of the gene therapy market in the projected timeframe. In particular, the American Cancer Society projected in January 2022 that there will be 1.9 million fresh diagnoses of cancer and around 609,360 cancer-related deaths in the United States alone, equating to approximately 1,670 fatalities daily. Lung, prostate, bowel, and female breast cancer are the four most common types, accounting for 43% of all new cases of cancer. Accordingly, the global rise in cancer rates is expected to stimulate demand for the gene therapy market in the coming years. One of the most effective treatment options in oncology is gene therapy, where new genes are introduced into a cancer cell or the surrounding tissue to inhibit cancer growth or result in cell death.
What are the market segments in the gene therapy industry?
The gene therapy market covered in this report is segmented –
1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy
2) By Vector: Viral Vector, Non-Viral Vector
3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders
4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users
Subsegments:
1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations
2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp
Which leading companies are shaping the growth of the gene therapy market?
Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi
What key trends are currently impacting the gene therapy market’s development?
The gene therapy market is increasingly embracing machine learning and artificial intelligence (AI). AI mimics human intelligence within machines that have been programmed to express inherent intelligence. Machine learning, a subset of AI, in tandem with AI assists businesses in the gene therapy arena to conduct exhaustive analysis of pertinent data. They decipher the relationship between tumor and immune cell interactions and provide a more precise assessment of tissue samples, which is often a point of contention among various evaluators. For example, Form Bio, an American life-sciences software firm pioneered FORMsightAI, a novel AI-run solution set for forecasting and enhancing manufacturing yields of cell and gene therapy structures in May 2023. This comprehensive solution merges innovative, flexible AI models with Form Bio’s foundational platform and a seasoned team of computational life sciences experts equipped with know-how in biology, bioinformatics, and data science. FORMsightAI tackles recurrent challenges encountered by cell and gene therapy developers such as construct truncations and manufacturing contaminations. These are leading reasons for deeply unsatisfactory manufacturing yields, protracted market entry timelines, and issues concerning therapeutic safety.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395
Which geographic areas are influencing the growth of the gene therapy market?
North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth
https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market
CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery
https://www.thebusinessresearchcompany.com/report/car-t-therapy-market
Nucleic Acid Based Gene Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
